COSMOS Pharmaceutical Corp. Hits Day Low at JPY 7,291 Amid Price Pressure

COSMOS Pharmaceutical Corp. experienced significant volatility on October 15, 2025, with the stock declining by 11.17% and reaching an intraday low of JPY 7,291.00. This performance starkly contrasts with the Japan Nikkei 225, which fell by only 2.58% on the same day. Over the past week, COSMOS has seen a decrease of 9.16%, while its monthly performance reflects a more substantial decline of 16.48%.
Despite these short-term challenges, COSMOS has shown resilience over the past year, with a modest gain of 3.29%. However, its long-term performance remains concerning, as it has dropped 16.31% over the last five years, compared to the Nikkei's impressive 98.28% increase during the same period.

The company's financial metrics indicate a solid long-term fundamental strength, highlighted by an average Return on Equity (ROE) of 12.99% and a healthy annual growth rate in net sales of 8.92%. Nevertheless, COSMOS has reported negative results for the last four consecutive quarters, raising questions about its current market position.